Budapest, Hungary

Sándor Sólyom

This inventor holds 1 USPTO granted patent. Top assignee: Ivax Drug Research Institute. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sándor Sólyom. Retrieved from https://idiyas.com/inventor/sándor-sólyom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Sándor Sólyom

Introduction: Sándor Sólyom is a notable inventor based in Budapest, Hungary, recognized for his contributions to the field of pharmaceutical sciences. He holds a patent for substituted 2,3-benzodiazepine derivatives, showcasing his innovative approach to addressing complex medical conditions.

Latest Patents: Sándor Sólyom's patent focuses on new 2,3-benzodiazepine derivatives of formula (I), along with their isomers and acid addition salts. The invention is significant as it relates to pharmaceutical compositions that are designed to treat conditions associated with muscle spasms and epilepsy. Furthermore, these derivatives are being explored for their potential in managing acute and chronic neurodegenerative diseases, as well as alleviating symptoms of inflammatory disorders.

Career Highlights: Throughout his career, Sándor has worked at the Ivax Drug Research Institute, where he has further developed his innovative ideas into viable pharmaceutical solutions. His commitment to research and development has significantly influenced advancements in drug therapies applicable to various medical conditions.

Collaborations: In his professional journey, Sándor Sólyom has collaborated with esteemed colleagues such as Gizella Ábrahám and Tamás Hámori. Together, they have contributed to the innovative landscape of pharmaceuticals, merging their expertise to enhance the potential of their research and development efforts.

Conclusion: Sándor Sólyom exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborative efforts with fellow researchers illustrate a dedicated pursuit of solutions for pressing health challenges. As a man of science, he continues to influence the future of drug development, ensuring advancements that positively impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…